GSK plans $30 billion US investment as pharma tariff threat looms
PositiveFinancial Markets

GSK has announced a significant $30 billion investment in the U.S., a move that underscores its commitment to expanding its operations and innovation in the pharmaceutical sector. This investment comes at a time when the company faces potential tariff threats, making it crucial for GSK to strengthen its presence in the American market. This decision not only highlights GSK's confidence in the U.S. economy but also promises to create jobs and enhance healthcare solutions for patients.
— Curated by the World Pulse Now AI Editorial System